Peter Welford

Stock Analyst at Jefferies

(2.44)
# 2,227
Out of 4,792 analysts
13
Total ratings
80%
Success rate
5.9%
Average return

Stocks Rated by Peter Welford

GSK plc
Nov 12, 2024
Downgrades: Hold
Price Target: n/a
Current: $37.64
Upside: -
Novartis AG
Sep 3, 2024
Downgrades: Hold
Price Target: n/a
Current: $110.77
Upside: -
AstraZeneca
Jan 3, 2024
Downgrades: Hold
Price Target: n/a
Current: $72.22
Upside: -
Galapagos NV
Jan 23, 2023
Upgrades: Hold
Price Target: $49$47
Current: $24.50
Upside: +92.65%
Genmab
Sep 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $18.82
Upside: -